Skip to main content

Published locations for Filgotinib shows efficacy, safety in RA phase 3 and PsA phase 2 trials

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Filgotinib shows efficacy, safety in RA phase 3 and PsA phase 2 trials

User login

  • Reset your password
  • /content/filgotinib-shows-efficacy-safety-ra-phase-3-and-psa-phase-2-trials
  • /internalmedicinenews/article/190095/rheumatoid-arthritis/filgotinib-shows-efficacy-safety-ra-phase-3
  • /rheumatologynews/article/190095/rheumatoid-arthritis/filgotinib-shows-efficacy-safety-ra-phase-3-and
  • /rheumatology/article/190095/rheumatoid-arthritis/filgotinib-shows-efficacy-safety-ra-phase-3-and-psa
  • /internalmedicine/article/190095/rheumatoid-arthritis/filgotinib-shows-efficacy-safety-ra-phase-3-and
  • /rheumatology/psoriatic-arthritis-resource-center/article/190095/rheumatoid-arthritis/filgotinib
  • /dermatology/psoriasiscollection/article/190095/rheumatoid-arthritis/filgotinib-shows-efficacy-safety
  • /psoriatic-arthritis-icymi/article/190095/rheumatoid-arthritis/filgotinib-shows-efficacy-safety-ra